Giuseppe Ruvio

Giuseppe Ruvio is an accomplished expert in engineering and medical devices with extensive experience in both academia and industry. Currently serving as Chief Scientific Officer at Endowave since January 2020, Giuseppe has led the development of a minimally invasive treatment for lung cancer utilizing innovative microwave ablation technology. Prior roles include Medical Device Development at the National University of Ireland, Galway, focusing on the commercialization of technology through the Enterprise Ireland Commercialisation Fund Programme, and consulting at Decawave, where Giuseppe contributed to advanced semiconductor solutions. Giuseppe's academic background includes research fellowships at Trinity College Dublin and Dublin Institute of Technology, focusing on microwave technologies and sensor design. Educational qualifications include a Ph.D. in Electrical and Electronics Engineering from Technological University Dublin, a Specialist Master in Management in Clinical Engineering from Università degli Studi di Trieste, and a Master of Science in Telecommunications Engineering from Università di Siena.